#4 Conclusions
The ability to match both location (means) & spread (SDs) between IPD and aggregate/study-level data is critical in order to reliably estimate the statistical significance of indirect treatment comparisons. Current comparative effectiveness methods fail to match both location and spread -our novel approach provides a solution to this problem.
#2 Methods
Our method matches both means and standard deviations (SDs) across multiple baseline patient characteristics between IPD and aggregate data. 
Repeat steps 1-4 thousands of times
6. Identify the optimal weights such that the differences in means and SDs between the weighted IPD vs. aggregate data are as small as possible 7. Run the standard ITC analysis, but using the set of weights identified in step 6 to re-weight the IPD. As can be seen in Table 1 , our newly developed Weighted-IPD method was extremely successful in matching both the means and SDs across these two predictors of treatment efficacy.
#3 Results
Any subsequent statistical analysis comparing the efficacy outcomes between these two treatments could then easily incorporate these weights. Essentially, we can then address important questions such as:
"What efficacy response would we have observed in our clinical trial if we had enrolled similar patients to our competitor?" #2 Methods (cont.)
The Weighted-IPD method is depicted visually in Figure 1 .
We highlight this method here with a case study of anti-VEGF therapies in the treatment of visual impairment due to diabetic macular edema. Our aim was to re-weight the IPD such that the baseline visual acuity (BCVA) and retinal thickness (CRT) matched the aggregate data. The studies included in the IPD and aggregate data all contained laser as their standard therapy. Our ultimate goal was to make a more accurate efficacy comparison of the two anti-VEGF treatments arms (IPD vs. aggregate). 
